|
Dr. Rafii is the Arthur B. Belfer Professor of Genetic Medicine at Weill-Cornell Medical College. Dr. Rafii, who is a board certified Hematologist-Oncologist, is engaged in patient care, and basic and translational research. He has expertise in basic tumor biology as well as vascular and stem cell biology. He was recently appointed to spearhead the Ansary Stem Cell Center for Regenerative Medicine at Weill-Cornell.
Dr. Rafii graduated from Cornell University in 1982, with a degree of Cum Laude in Chemistry and was awarded Phi Beta Kappa. He received his MD degree from Albert Einstein College of Medicine with Honors and was elected to AOA society in 1986. Subsequently, in 1989, he completed his internship and residency in Internal Medicine followed by a fellowship in Hematology-Oncology at Weill-Cornell in 1992. By 1996, he completed his post-doctoral training in vascular and hematopoietic stem cell biology under supervision of Dr. Ralph Nachman at Weill-Cornell. He became a full professor in Genetic Medicine in 2002, at which time he was appointed to be the co-director of the Ansary Stem Cell Center.
Dr. Rafii is funded by multiple R01 grants from the NIH's Heart, Lung and Blood Institute, and is an active charter member of the Tumor Microenvironment Study Section at the National Cancer Institute. He is an elected member of the American Society of Clinical Investigation (Young Turks), an American Cancer Society Scholar, and a Translational Researcher of the Leukemia and Lymphoma Society.
He has organized Keystone conferences, and actively participates in stem cell meetings both in the U.S.A., and internationally. He has trained many post-doctoral graduate students, and others, resulting in being appointed to independent tenure track positions in the U.S.A., Europe, and Japan. He is a consulting editor for the Journal of Clinical Investigation and is a member of Editorial Board of Stem Cells Journal and Journal of Cardiovascular Regeneration.
Dr. Rafii is principal inventor in several patents on therapeutic use of vascular stem cells for organ regeneration. Many of his basic science findings have endured the scrutiny of scientific enquiry and have been translated into the clinical arena. | 